Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Sep 5, 2012

30016_dirs_2012-09-05_e5411d22-ceba-4318-a13d-68cd3e8c6548.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-09-01

Reporting Person: SZOSTAK M ANNE (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-09-01 Non-Qualified Stock Option (right to buy) $95.06 A 2953 Acquired 2019-08-31 Common Stock (2953) Direct
2012-09-01 Deferred Stock Unit $ A 284 Acquired Common Stock (284) Direct

Footnotes

F1: Grant of options to buy shares of common stock that vest 100% on 05/09/2013.

F2: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest 100% on 05/09/2013 and are payable as common stock one year following the Director's resignation from the Board of Directors.